Perpetua Medical AB (publ) (STO:PERP.B)

Perpetua Medical AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	20.28	4.33	9.4	5.53	10.69	19.06
Cash & Short-Term Investments	20.28	4.33	9.4	5.53	10.69	19.06
Cash Growth	181.21%	-53.90%	69.89%	-48.26%	-43.89%	15.98%
Accounts Receivable	4.83	5.17	1.99	2.17	3.09	2.5
Other Receivables	7.48	8.04	0.72	1.27	1.95	1.84
Receivables	12.31	13.21	2.71	3.44	5.04	4.34
Inventory	0.95	0.87	0.77	0.58	0.66	0.24
Prepaid Expenses	0.76	0.46	-	0.12	0.11	0.1
Other Current Assets	0	-	0	-	-	-
Total Current Assets	34.31	18.88	12.88	9.66	16.51	23.74
Property, Plant & Equipment	1.09	1.16	0.01	0.07	0.62	0.47
Long-Term Investments	0.81	-	-	-	-	-
Goodwill	-	17.46	5.77	-	-	-
Other Intangible Assets	22.78	3.53	-	-	-	0.05
Long-Term Deferred Tax Assets	-	0.46	-	-	-	-
Long-Term Deferred Charges	-	1.71	0.03	2.17	1.66	0.77
Other Long-Term Assets	-	19.03	0.05	0.4	0.06	0.56
Total Assets	58.98	62.22	18.75	12.31	18.85	25.59

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.86	2.06	1.39	1.18	1.48	1.77
Accrued Expenses	2.58	2.04	0.36	0.98	1.01	0.87
Current Portion of Long-Term Debt	0.18	0.18	-	0.06	0.33	0.33
Current Portion of Leases	-	0.18	-	-	-	-
Current Income Taxes Payable	-	-	-	-	-	0.05
Current Unearned Revenue	0.42	0.94	-	-	-	-
Other Current Liabilities	1.45	2.03	1.58	2.03	1.95	1.32
Total Current Liabilities	6.5	7.43	3.33	4.24	4.76	4.35
Long-Term Debt	12.42	11.7	4	-	0.06	0.42
Long-Term Leases	-	0.77	-	-	-	-
Long-Term Deferred Tax Liabilities	1.44	1.47	0.55	-	-	-
Other Long-Term Liabilities	10.08	10.08	-	-	-	-
Total Liabilities	30.44	31.44	7.88	4.24	4.82	4.76

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	2.05	1.09	1.09	11.73	11.68	9.22
Additional Paid-In Capital	20.05	19.55	0.03	2.17	1.66	18.78
Comprehensive Income & Other	-3.85	-0.87	6.73	-5.83	0.68	-7.17
Total Common Equity	18.25	19.76	7.85	8.07	14.03	20.83
Minority Interest	10.29	11.01	3.02	-	-	-
Shareholders' Equity	28.54	30.77	10.87	8.07	14.03	20.83
Total Liabilities & Equity	58.98	62.22	18.75	12.31	18.85	25.59

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	12.6	12.82	4	0.06	0.39	0.75
Net Cash (Debt)	7.69	-8.49	5.4	5.48	10.3	18.31
Net Cash Growth	139.22%	-	-1.41%	-46.84%	-43.72%	19.06%
Net Cash Per Share	1.36	-1.82	1.27	3.16	15.07	32.29
Filing Date Shares Outstanding	8.56	8.33	4.52	2.76	0.81	0.64
Total Common Shares Outstanding	8.56	4.52	4.52	2.76	0.81	0.64
Working Capital	27.81	11.45	9.54	5.42	11.74	19.4
Book Value Per Share	2.13	4.37	1.74	2.92	17.29	32.52
Tangible Book Value	-4.53	-1.22	2.08	8.07	14.03	20.78
Tangible Book Value Per Share	-0.53	-0.27	0.46	2.92	17.29	32.44
Machinery	-	1.34	0.35	0.2	1.55	1.24

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 12, 2026

Data Sources Report a data error